Analysts See $-0.10 EPS for Codexis, Inc. (CDXS) on May, 8

April 16, 2018 - By Jenna Rose

Codexis, Inc. (NASDAQ:CDXS) Corporate Logo
Big Money Sentiment decreased to 2.17 in Q4 2017. It has change of 0.03, from 2017Q3’s 2.2. The ratio dived due to Codexis, Inc. positioning: 3 sold and 15 reduced. 12 funds took stakes and 27 increased stakes. Investors holded 25.60 million in 2017Q3 but now own 28.02 million shares or 9.42% more.
Moreover, Morgan Stanley has 0% invested in Codexis, Inc. (NASDAQ:CDXS) for 91,201 shs. Rhumbline Advisers has invested 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). Guggenheim Ltd Liability Corporation holds 0% in Codexis, Inc. (NASDAQ:CDXS) or 10,184 shs. State Board Of Administration Of Florida Retirement Systems invested 0% in Codexis, Inc. (NASDAQ:CDXS). Fmr Limited Liability Co has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Goldman Sachs Group has 41,931 shs for 0% of their capital. Blair William And Il has invested 0.01% in Codexis, Inc. (NASDAQ:CDXS). Jpmorgan Chase reported 8,800 shs. Metropolitan Life Communications Ny invested 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). Comml Bank Of America De has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Bnp Paribas Arbitrage holds 8,079 shs or 0% of its capital. The Germany-based Deutsche Natl Bank Ag has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Tower Rech Capital Ltd (Trc) has invested 0.01% in Codexis, Inc. (NASDAQ:CDXS). American Gru invested 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). Wells Fargo Mn reported 1.00M shs or 0% of all its holdings.

Codexis, Inc. had 5 selling transactions and 0 insider purchases since March 21, 2018. This’s net activity of $1.19 million. $276,318 worth of Codexis, Inc. (NASDAQ:CDXS) was sold by BARUCH THOMAS R on Wednesday, March 28. Smith David V sold $62,213 worth of Codexis, Inc. (NASDAQ:CDXS) or 6,000 shs on Tuesday, April 3. $124,683 worth of stock was sold by KELLEY BERNARD J on Wednesday, March 21. NICOLS JOHN J sold $259,828 worth of stock.

Codexis, Inc. (NASDAQ:CDXS) is expected to announce earnings on May, 8., according to Zacks. Last year’s EPS was $-0.18, while now analysts expect change of 44.44 % up from current $-0.10 EPS. -600.00 % negative EPS growth is what Wall Street’s predicts after $0.02 reported EPS last quarter. On during the last trading session the stock decreased $0.3 or 2.63%, reaching $11.1.Currently Codexis, Inc. is uptrending after 125.77% change in last April 17, 2017. CDXS has also 254,856 shares volume. CDXS outperformed by 114.22% the S&P500.

Codexis, Inc. discovers, develops, and sells protein catalysts.The firm is valued at $584.72 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening.Currently it has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Codexis, Inc. (NASDAQ:CDXS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.